2000 Subject index for Communicable Diseases Intelligence - Volume 24

This page contains an index by subject of articles that were published in Communicable Diseases Intelligence during 2000.

Page last updated: 22 January 2001

Subject index, 2000

A print friendly PDF version (PDF 55 KB) is available.

A | B | C | D | E | F | G | H | I | J-K | L | M | N | O | P | Q | R | S | T | U-V | W | X-Y-Z

Top of page

A

Abattoir workers; 154-156, 158-160, 384

Absenteeism, Australia Post; 10, 55-56, 137, 215, 246-247, 279-280, 312

Aboriginal; 48-50, 90-92, 93-94, 165, 343, 368-372, 384, 386-389

ACIR
       See: Australian Childhood Immunisation Register

Acute flaccid paralysis; 8, 119-120, 300-303, 364

Acute febrile illness
       USA; 296

Adverse Drug Reactions Committee; 28-29

Adverse Event Following Immunisation (AEFI)
       adverse events, definitions; 32-33
       AEFI definition; 257-258
       report; 257-258
       measles; 27-33

Aedes spp; 327, 365-366

AIDS
       See: HIV and AIDS

Anaphylaxis; 8, 28-31, 258

Anthrax
       overseas brief, Ethiopia; 227
       reporting; 373

Antibiotic
       animal feed; 297-298
       azithromycin; 389
       doxycycline; 407
       pertussis, and; 376-379
       resistance
              editorial; 297-298
             Expert Advisory Committee on Antibiotics; 298
              gonococcal; 1-4, 9, 194, 269-271
              pneumococcal; 340-343
             virginiamycin; 298
              see also: JETACAR
       susceptibility; 1-4, 182-188, 193, 194, 256, 273, 341
              amoxycillin; 17, 63, 115, 256, 289, 343
              ampicillin; 17, 63, 115, 256, 289
              cephalosporin; 3, 63, 91, 114-115, 186, 188, 271, 289, 340-342
              cefotaxime; 341-342
              ceftriaxone; 3, 9, 18, 64, 115, 116, 186, 256, 290
              chloramphenicol; 4, 188
              ciprofloxacin; 2, 9, 18, 64, 115, 116, 256, 290, 362
              erythromycin; 91, 341-342
              furazolidone; 362
              norfloxacin; 362
              penicillin; 2, 9, 17, 90, 91, 115, 185, 193, 256, 269, 270, 289, 290, 340-343
              penicillinase-producing Neisseria gonorrhoeae (PPNG); 2, 17, 63, 64, 115, 193, 194, 256, 269, 289, 290
              quinolone; 2, 3, 18, 64, 114-116, 188, 256, 269, 270
              quinolone-resistant Neisseria gonorrhoeae (QRNG); 2, 18, 116, 256, 270, 290
              rifampicin; 186, 188, 341-342
              spectinomycin; 3, 9, 18, 64, 114-116, 256, 269, 271, 290
              tetracycline; 3, 18, 114-116, 271, 341-342, 362
              tetracycline resistant Neisseria gonorrhoeae (TRNG); 9, 17, 18, 64, 115, 116, 271, 290
              thiamphenicol; 4
              vancomycin; 341-342

Antimalarial; 394, 407

ANZFA
       See: Australian and New Zealand Food Authority

Arboviruses
       reporting; 373
       surveillance report; 127, 170

Arthritis; 31, s69, 333

ASPREN
       See: Australian Sentinel Practice Research Network

Australian and New Zealand Food Authority; 95, 385

Australian Childhood Immunisation Register; 8, 52, 161-164, 260
       See also: Childhood Immunisation Coverage, reports

Australian encephalitis
       See Sentinel Chicken Surveillance Programme

Australian Gonococcal Surveillance Programme; 9, 190-191
       See also: Gonococcal, surveillance; National Neisseria Network

Australian Malaria Register; 6

Australian Meningococcal Surveillance Programme; 186, 191-193
       See also: Meningococcal, surveillance

Australian Mycobacterium Reference Laboratory Network; 6

Australian National Polio Reference Laboratory; 6
       report; 118-121, 300-303
       See also: Polio

Australian National Polio Certification Committee; 300

Australian Paediatric Surveillance Unit; 6, 120, 300-302

Australian Sentinel Practice Research Network
       surveillance
              data in CDI, explanation; 7-8, 146-147, 149
              non-notifiable disease reporting; 373
              influenza; 136, 146, 215, 246-247, 279-280, 311-312, 379-383
              report; 16, 40, s85, 106, 135, 136, 177, 221, 255, 289, 321, 359

Top of page

B

Barmah Forest virus; 170, 363
       surveillance report; 393
       warning; 363

Bloodborne diseases
       surveillance report; 56, s78, 96, 126, 169

Boat people; 25-26, 386-389, 394

Bordetella pertussis
       See: Pertussis

Botulism; 12

Bovine spongiform encephalopathy (BSE)
       beef imports, suspension; 385
       blood donors
       Australia; 267
       CJD, variant, and; 265-266
       editorial; 265-266
       overseas briefs
       France; 309, 362-363
       Germany; 362
       Spain; 362
       United Kingdom; 295, 309, 326
Top of page

C

Campylobacter spp.; 49-50
       surveillance report; 348-349, 391

Case definition; 121, 147, 272, 299, 329-331, 337, 344, 373, 376, 380, 383, 387

CDI
       See: Communicable Diseases Intelligence

CDNANZ
       See: Communicable Diseases Network Australia New Zealand

Chickenpox
       See: Australian Sentinel Practice Research Network

Childhood Immunisation Coverage
       letter; 260, 268
       pertussis; 375-379
       re-evaluation of estimates; 161-164, 260, 268
       summary, 1993-1998; 276, 277
       surveillance report, quarterly; 42, 109, 225, 324

Chlamydia
       azithromycin; 389
       screening; 390
       surveillance report; s78-s79, 96, 126, 169, 213, 349, 392

Cholera
       overseas briefs
       Afghanistan; 296
       Comoros; 20
       Madagascar; 44, 67, s88
       Marshall Islands; 406
       Pohnpei, Micronesia; 143, 179, 227, 295-296, 363-364
       Somalia; 144
       South Africa; 326
       surveillance report; s78

Ciguatera poisoning, outbreak; 344-346

Classical CJD (cCJD)
       See: Creutzfeldt-Jakob disease

CJD
       See: Creutzfeldt-Jakob disease

Communicable Diseases Intelligence
       editorial
       antibiotic resistance; 297
       CDI, future; 374
       CJD surveillance; 265-266
       measles
              case definition, surveillance and; 329-331
              vaccination; 241-242
       national disease reporting; 373-374
       letters to the Editor; 260, 268, 299, 331
       publication; s72, 374
       supplements
       March; s69-s88
       June; Vaccine Preventable Diseases, 1993-1998
       Technical Report Series, No 5; 241-242, 277, 299, 331
       surveillance data in CDI, explanation; 6-10, 34, 55, s77, 96, 281

Communicable Diseases Network Australia New Zealand; 6, 373, 374

Communicable diseases surveillance
       definition; 6, 373
       enhanced; 125, 199, 329-331, 332-335, 336, 373
       national reporting; 373-374
       immigrants; 21-26
       report; 11-17, 17-19, 35-40, 40-42, 55-63, 63-65, s77-s85, s86, 96-106, 107-109, 126-136, 136-140, 168-177, 178, 213-221, 222-225, 243-255, 256-259, 278-289, 289-292, 310-312, 322-324, 348-359, 360-361, 391-404, 404-405

tables; 13-17, 36-40, 57-63, s81-s85, 99-106, 129-136, 171-177, 215-221, 247-255, 280-289, 313-319, 319-321, 351-357, 357-359, 395-401, 401-404

Corynebacterium diphtheriae
       See: diphtheria

Coxsackie virus; 301

Creutzfeldt-Jakob disease (CJD, cCJD, vCJD)
       blood donation; 266, 267
       editorial; 265-266
       iatrogenic vCJD; 264, 265-266
       overseas briefs
       France; 20
       Germany; 363
       United Kingdom; 20, 295, 326
       surveillance; 265-266
       variant CJD (vCJD); 265-266
       See also: Bovine spongiform encephalopathy

Cruise ship; 45-47, 294-295

Crimea-Congo haemorrhagic fever; 180, 373

Cryptosporidiosis
       outbreak; 236-239
       reporting; 373

Culex spp.; s74, s75, 369-370

Top of page

D

Dengue
       control measures; 365-368
       East Timor, persons returning from; 365-368
       overseas briefs, Palau, Micronesia; 328, 406
       rash; 329, 366
       surveillance
              advanced; 365-367
              report; 12, 35, 56, s79, 96, 127, 170

Diarrhoea
       See: gastrointestinal disease

Diphtheria
       ASPREN; 8
       Australian trends, review; 165-167
       New Zealand; 167
       Soviet Union; 166
       summary 1993-1998; 276
       See also: Childhood Immunisation Coverage

Drugs, illicit; 203-205

Dysentery, Sierra Leone, Lesotho; 44

Top of page

E

East Timor; 25, s80, 235, 365-368, 407

Ebola haemorrhagic fever
       overseas brief, Uganda; 326, 408
       reporting; 373
       vaccine; 362

Echovirus
       outbreak; 121-124
       overseas brief, South East Asia; 327
       surveillance report; s72, 98

Editorial
       See: Communicable Diseases Intelligence

Encephalitis
       case; 291, 368-372
       surveillance report; 213, 246, 360
       warning; 246
       see also: Japanese encephalitis, Murray Valley

Encephalopathy; 8, 28, 30-32

Enteroviruses
       identification; 118-120, 208-209, 300-302, 406
       isolation; 300-303
       overseas briefs
              Korea; 295
              South East Asia; 327, 406
       See also: echovirus, polio, coxsackie

Erythema infectiosum; s69-s71

Escherichia coli
       drinking water; 49, 337
       overseas briefs
       Canada; 180
       Spain; 406
       shiga-like toxin (verotoxin) producing; 12
       surveillance report; 12, 56, s78, 96, 169, 243, 310, 349, 391

Top of page

F

Flavivirus
       surveillance report; 40, s86, 138-139, 360
       Townsville; 367
       Western Australia; 368-370, 372
       See also: individual diseases, viruses, Sentinel Chicken Surveillance Programme

Food policy; 95, 385

Foodborne disease; 48
       global salmonella surveillance; 228
       outbreak; 303, 344-346, 347a, 347b
       regulation Review; 95
       sentinel surveillance; 95
       Staphylococcus aureus, Japan; 227
       surveillance report; 57, 243, 349
       typhoid; 235
       vCJD; 266, 385
       See also: gastrointestinal disease; ciguatera poisoning

Food-producing animals, antibiotics and; 298

Top of page

G

Gastrointestinal disease;
       adverse event following immunisation; 258
       ASPREN; 8
       ciguatera poisoning; 344-346
       cryptosporidiosis; 236-239
       India; 362
       immigrants; 24
       Norwalk-like virus, outbreak; 229-233
       rotavirus; 10, 195
       salmonellosis; 305-306, 336-340, 347a, 347b
       shigellosis; 246, 272-275
       Small Round Structured Virus; 48-50
       surveillance report; 12, 35, 56, 96, 126, 169, 213, 243, 310, 348, 391-392
       viral; 303

Gonococcal
       Advisory Group; 193
       annual report 1999 - surveillance; 113-117
       antibiotic
              resistance; 269-271
              susceptibility; 1, 17, 114-117, 190, 193, 194
       HIV, and; 269
       quarterly report; 17-18, 63-64, 256-257, 289-290
       screening; 390
       surveillance
             data in CDI, explanation; 9
              report; 1, 56, s79, 126, 169

Top of page

H

Haemolytic uraemic syndrome
       overseas brief; Spain; 406
       reporting; 373
       surveillance report; 12, 35, s78, 96, 126

Haemophilus ducreyi, chancroid; 269, 373

Haemophilus influenzae B
       quarterly review; 239
       summary 1993-1998; 276
       surveillance
              report; 97, 126, 214, 392
              scheme; 94
       See also: Childhood Immunisation Coverage

Haemorrhagic fever; s67, s88, 111, 366, 408
       overseas briefs
              Afghanistan; 180, 227, 263
              Congo; s67, s88, 111
       see also: dengue

Hand, foot and mouth disease
       Singapore; 295, 327
       South East Asia; 327, 406

Hantavirus

overseas brief; s67

Health
       drinking water; 338-339
       eating habits; 345
       environmental; 200-201
       facilities, measles in; 211-212
       hospital-acquired infection; 298
       infection control; 157, 298
       legislation; 373
       nursing home, gastroenteritis; 229-233, 272-274
       policy; 26
       Public Health Laboratory; 90, 91
       Public Health Unit (PHU)
              Alice Springs; 48
              Brisbane North; 230
              Brisbane South Side; 230, 236, 272-274
              Central, Rockhampton; 336
              Gasgoyne; 375, 377
              Kimberley; 386-387, 389-390
              Northern Rivers; 158
              South Coast; 272-274
              South East Sydney; 203, 233, 236, 305
              South Western Sydney; 121, 124
              Tropical; 211-212, 332, 366-367
              surveillance, role in; 332-335, 373
              West Moreton; 231
              Western Australia; 372
       refugees; 21-26
       swimming pool, codes of practice; 238

Hepatitis A
       outbreak report; 203-205
       surveillance report; 12, 35

Hepatitis B
       surveillance report; 243
       vaccine, adverse event; 257

Hepatitis C
       nosocomial transmission, Germany; 407-408
       publication, new; 275
       surveillance
             enhanced; 373
              report; 56, s78, 96, 126, 169

Herpes virus-6; 329

Hib Case Surveillance Scheme; 6

HIV and AIDS
       gonococcus, and; 269
       publication, new; 275
       surveillance
              data in CDI, explanation; 7
              report; 18, 19, 41, 64, 108, 139-140, 178, 224, 259, 292, 323, 360, 404-405

Hydrops fetalis; s69-s71

Top of page

I

Immigrants 20-26, 299, 366-367, 386, 388-389, 394

Immunisation
       coverage; 161-164, 260, 268, 276-277
       measles
             control; 54
              vaccine, possible adverse effects; 51
       See also: Adverse Event Following Immunisation; Australian Childhood Immunisation Register; Childhood Immunisation Coverage

Indigenous; 90, 93, 94
       See also: Aboriginal

Infantile diarrhoea; 373

Infection control; 157

Influenza
       ASPREN; 7, 379-383
       avian; 327
       case definition; 380, 383
       influenza A outbreak
              Fair Princess cruise; 294-295
              trans Tasman cruise; 45-47
      
       National Influenza Surveillance Scheme, Annual Report, 1999; 9, 145-152
       overseas brief
              Canada; 327
              Hong Kong; 327
              USA; 227
       surveillance
              data in CDI, explanation; 7, 9, 10
              report; 136, 137, 160, 214-215, 246-247, 257-258, 279-280, 311-312
       Tropical Influenza Surveillance; 9
       vaccination, NHMRC recommendations; 152
       vaccine composition
              for 2000 season; 152
              for 2001 season; 306, 384

Top of page

J

Japanese encephalitis
       reporting; 373
       surveillance; 373
       vector; s75
       See also: encephalitis

JETACAR
       See: Joint Expert Technical Advisory Committee on Antibiotic Resistance

Joint Expert Technical Advisory Committee on Antibiotic Resistance
       editorial; 297-298

K

Kosovo; 21, 24, 111

Kunjin virus
       reporting; 8, 373
       surveillance report; 18, s86, 138, 139, 223, 290
       Western Australia; 368-372

Top of page

L

LabVISE
       See: Virology and Serology Laboratory Reporting Scheme

Lassa fever
       overseas briefs
              Daru, Sierra Leone; 227
              Germany; 20, 44
              Netherlands; 228, 262
              United Kingdom; s88
              reporting; 373

Legionella spp; s72, 127, 170, 199, 311

Legionellosis
       editorial comment; s73
       Fair Princess cruise; 294-295
       outbreak report; s72, 92, 199-202
       overseas brief, Paris, 407
       surveillance report; 57, s80, 98, 127, 128, 170, 214, 279, 311, 350, 392-393
       testing; s73

Legionnaire's disease
       See: legionellosis

Leptospira spp.
       See: leptospirosis

Leptospirosis
       national surveillance; 153-157
       outbreak report; 158-160, 384

Letters to the Editor
       See: Communicable Diseases Intelligence

Lice; 25

Listeria monocytogenes
       See: Listeriosis

Listeriosis
       overseas briefs
              Canada; 296
              France; 67, 296
              USA; 296, 407
       surveillance report; 56, 214

Lower respiratory tract infection (LRTI)
       See: respiratory tract infection

Lyssavirus; 373

Top of page

M

Malaria
       Africa; 407
       Boat people; 394
       East Timor, persons returning from; 367
       surveillance report; s79, 80, 97, 127, 170, 279, 394
       See also: antimalarials

Marburg haemorrhagic fever
       overseas briefs, Congo; 67, s88, 111
       reporting; 373

Measles
       adverse event following immunisation; 27-33
       case definition; 329-331
       control campaign updates; 27, 54
       editorial; 241-242, 329-331
       Elimination Advisory Committee; 27, 241
       guidelines for control; 241, 299, 331
       letter; 299, 331
       outbreak report; 142-143, 211-212
       quarterly report; 240
       publication, new; 277
       overseas brief; Ireland; 263
       summary 1993-1998; 276
       surveillance
              enhanced; 329-331, 373
              report; 11, 55, 97, 127, 168, 214, 245, 278, 310, 311, 349, 392
       See also: Childhood Immunisation Coverage

Meningitis
       adverse event following immunisation; 258
       echovirus; 121-124
       overseas brief, Angola; 408
       pneumococcal; 342
       viral; s72
       See also: echovirus; meningococcal disease

Meningococcal disease
       antibiotic
              susceptibility; 185-186, 191-192
              use, in; 333-335
       Annual Report 1999, surveillance; 181-188
       pilgrims; 111-112
       outbreak report; 332-335
       overseas briefs
              Central African Republic; 67
              Ethiopia; s88, 111, 263
              France; 111, 144
              Hungary; 20
              international; 144
              Netherlands; 112, 144
              Oman; 111, 144
              Rwanda; 263
              Saudi Arabia;112, 114
              Sudan; 111
              United Kingdom; 111, 144
              USA; 112, 144
       surveillance
              enhanced; 332-335, 373
              report; 55, s72, s78, 98, 127, 170, 214, 246, 279, 311, 350, 393
Mosquito
       breeding; 363, 366-372, 394
       containment; 327, 365-367, 372
       exotic; s74, s75

Mumps
       adverse events; 27-33
       control campaign updates; 54
       quarterly report; 241
       summary 1993-1998; 276
       surveillance report; 97, 127, 168, 244, 278, 310
       See also: Childhood Immunisation Coverage

Murray Valley encephalitis
       encephalitis; 291, 368-372
       rash; 369-370
       virus activity,
              see: Sentinel Chicken Surveillance Programme
       reporting; 8, 373
       southerly spread; 368-372
       surveillance report; 18, s86, 127, 138, 139, 170, 222-223, 291

Top of page

N

National Centre for Disease Control
       food policy; 95
       workshop; 125

National Centre for Immunisation Research and Surveillance
       pneumococcal disease Workshop; 89
       publication, new; 210
       report; 241
       role; 125, 167, 241
       vaccination update workshop; 51

National Centre in HIV Epidemiology and Clinical Research; 7, 125

National Childhood Immunisation Program; 8, 28

National Enteric Pathogens Surveillance Scheme; 304

National Health and Medical Research Council; 6, 8, 27, 297-298, 337, 339, 373

National Influenza Surveillance
       See: Influenza

National Mycobacterial Surveillance System; 6

National Neisseria Network; 6, 182, 186-188, 190-193

National Notifiable Diseases Surveillance System; 6
       editorial; 373
       expanded surveillance; 125, 373
       diseases, revised list of notifiable; 242
       surveillance data in CDI, explanation; 6-10, 34, 55, s77, 96
       See also: Communicable Diseases Surveillance, report

National Plan for Poliovirus Containment; 207-210

National Polio Reference Laboratory; 300-303

National Rotavirus Reference Centre; 10, 107, 195

Neisseria gonorrhoeae
       See: Gonococcal

Neisseria meningitidis
       See: Meningococcal

New variant Creutzfeldt-Jakob disease
       See: Creutzfeldt-Jakob disease

NCIRS
       See: National Centre for Immunisation Research and Surveillance

NNDSS
       See: National Notifiable Diseases Surveillance System

Norwalk-like virus; 48-49
       outbreak report; 229-232
       surveillance report; 391

Notifiable diseases
       See: National Notifiable Diseases Surveillance System

Top of page

O

Operation Save Haven; 21-26

Ornithosis
       outbreak report; 350
       surveillance report; 12

Otitis media; 90

Overseas briefs; 20, 44, s67, s88, 111, 112, 144, 227-228, 262-264, 294-296, 326-328, 362-364, 406-408

Overseas travel; 46-47, 54, s76, 111, 234-235, 243-245, 364, 382-383

Top of page

P

Parainfluenza virus, surveillance report; 128

Paratyphoid fever; 233-236

Parotitis; 31

Parvovirus
       B19, in pregnancy; s69-s71
       rash; 329

Pertussis
       antibiotic use; 91, 378
       case definition; 376
       outbreak; 375-379
       quarterly report; 240
       summary 1993-1998; 276
       surveillance report; 11, 35, 55, s77, 97-98, 126-127, 168, 245, 278, 310-311, 349, 392
       See also: Childhood Immunisation Coverage

PHLN
       See: Public Health Laboratory Network

Pilgrim; 54, s76, 111-112

Plasmodium spp.
       surveillance report; s80, 97, 127, 170, 394
       See also: malaria

Pneumococcal disease
       antibiotic susceptibility; 90-92, 93-95, 340-343
       surveillance; 93-95
       enhanced; 373
       workshop report; 89-92

Pneumonia; 151-152

pneumococcal; 90, 340-343

Polio
       eradication; s76, 118-120, 207-210, 300-303, 304
       global; 304
       outbreak
       China; 44
       Dominican Republic and Haiti; 364
       summary 1993-1998; 276
       vaccine
              adverse event following immunisation; 258
              India; s76
              quarterly report; 240
       virus
              characterisation; 300-303
              Sabin; 301-302, 364
              wild, containment; 207-210, 300-303, 304
       See also: acute flaccid paralysis; Australian National Polio Reference Laboratory; Childhood Immunisation Coverage

Pregnancy; 24, s69-s71, 299, 387, 389

Psittacosis; 350
       See also: ornithosis

Public Health Laboratory
       See: Health

Public Health Laboratory Network; 125, 307, 373

Public Health Unit
       See: Health

Puerperal fever; 373

Top of page

Q

Quarantinable disease
       surveillance report; 56, s78, 96, 126, 169

Quarantine Act; 373

Top of page

R

Rash; 22, 31, s69, 329, 366, 370

Refugees 21
       See also: boat people, immigrants

Respiratory syncytial virus (RSV); 376, 381

Respiratory tract infection; 7, 24, 45-47, 341-342, 375-379, 380-383

Rift Valley fever
       overseas brief, Saudi Arabia; 295

Ross River virus; 363
       surveillance report; 11-12, 35, 37, s79, 96-97, 127, 170, 393-394
       warning; 363, 393-394

Rotavirus
       National Rotavirus Reference Centre report 1999/2000; 195-198
       quarterly report; 322
       surveillance data in CDI, explanation; 10, 195
       surveillance report, biannual; 107

Rubella
       adverse events following immunisation; 27-33
       control campaign update; 54
       letter; 299
       quarterly report; 240
       rash; 329
       summary 1993-1998; 276
       surveillance report; 11, 55, s77, 97-98, 127
       See also: Childhood Immunisation Coverage

Top of page

S

Salmonella spp
       See: Salmonellosis, typhoid

Salmonellosis
       drinking water; 336-340
       global surveillance; 228
       outbreak report; 305-306, 336-340, 347a, 347b
       overseas briefs
              India 362
              New Zealand, birds; 294
       surveillance report; 56, s78, 96, 126, 169, 213, 243, 348, 391
       see also: typhoid

Scabies; 25

Scarlet fever; 373

Sentinel Chicken Surveillance Programme
       surveillance
              data in CDI, explanation; 8-9
              report; 18, 40, s86, 138-139, 222-223, 291, 360
              Western Australia; 369-372

Serious Adverse Events following Vaccination Surveillance Scheme; 8
       See also: Adverse Events Following Immunisation

Shiga-like toxin
       See: Escherichia coli

Sexually transmissible diseases
       publication, new; 275
       surveillance in Australia; 7
       surveillance reports; 56, s78, 96, 126, 169
       see also: chlamydia, gonococcal, syphilis

Shigella spp
       See: shigellosis

Shigellosis
       outbreak report; 247, 272-275
       surveillance report; 257-258

SLTEC
       See: Escherichia coli

Small Round Structured Virus; 48-50, 229

Smallpox; 179, 373

Staphylococcus aureus
       food poisoning, Japan; 227
       methicillin-resistant; 297

Streptococcus pneumoniae
       See: pneumococcal disease

Surveillance
       data in CDI, explanation; 6-10, 34, 55, s77, 96, 281
       definition; 6, 373
       enhanced; 125, 373
       See also: Communicable Diseases Surveillance

Syphilis
       azithromycin; 389
       case definition; 387
       screening; 386-390
       surveillance report; s79, 126, 169

Top of page

T

Tetanus
       ASPREN; 8
       quarterly report; 241
       summary 1993-1998; 276
       surveillance report; 55, 97
       See also: Childhood Immunisation Coverage

Tuberculosis; 22, 125
       enhanced surveillance; 373
       evacuees, Kosovo; 22
       World Tuberculosis Day; s72

Tularemia, Kosovo; 111

Typhoid
       overseas brief, Samoa; 264
       surveillance report; 56, s78, 96, 126, 169, 243, 278, 349, 391
       Sydney, south eastern, 1992-1997; 233-236

Typhus; 394

Top of page

U

Upper respiratory tract infection (LRTI)
       See: Respiratory tract infection

V

Vaccinia; 179

Vaccination
       adult diphtheria/tetanus (ADT); 8, 167
       adverse events; 51
       definitions; 32-33
       measles; 27-33
       report; 257-258
       incentives; 51-53
       influenza; 379-383
       measles; 27-33, 241-242, 329
       meningococcal; 335
       MMR, adverse events; 27-33, 256-257
       pertussis; 245, 375-379
       pneumococcal; 89-95
       providers; 52
       recommendations; 27, 47, 94, 152, 167, 241-242
       summary 1993-1998; 276-277
       yellow fever; 54, s76, 263
       young adults;
       See: vaccination, measles
       See also: Adverse Event Following Immunisation, Childhood Immunisation Coverage; Immunisation

Vaccine
       adult diphtheria/tetanus (ADT); 165
       ebola virus; 362
       hepatitis A; 205
       influenza; 152, 306, 384
       measles/mumps/rubella; 27-33, 241
       pertussis; 375
       pneumococcal; 89-95, 343
       poliovirus; 207-210, 300-303, 304, 364
       rotavirus; 195, 197

Vaccine preventable diseases
       measles outbreak; 211-212
       publication review; 276-277
       summary; 210
       quarterly report; 239-241
       surveillance report; 11, 35, 55, s77-s78, 97-98, 126-127, 168, 214, 244, 278, 310, 349-350, 392
       See also: Childhood Immunisation Coverage

Variant CJD (vCJD)
       See: Creutzfeldt-Jakob disease

Varicella
       See: chickenpox

Variola; 179

Vector; 57, s74-s75

Vectorborne diseases, surveillance report; 11-12, 35, 56, s79-s80, 96-97, 127, 170, 393

Verotoxin
       See: Escherichia coli

Vibrio cholerae
       See: cholera

Victorian Infectious Diseases Reference Laboratory; 207-210, 380-383

Virginiamycin; 298

Virology and Serology Laboratory Reporting Scheme, 373
       influenza surveillance; 146-149
       report
              See: Communicable Diseases Surveillance, report
       surveillance data in CDI, explanation; 10

VTEC
       See: Escherichia coli

Top of page

W

Waterborne disease; 48-49, 336-340

West Nile fever
       overseas briefs
             Israel; 296
              USA; 326, 408
       transmission; 326

Whooping cough
       See: pertussis

World Health Organization (WHO)
       containment of antimicrobial resistance; 297
       diagnostic kit, influenza; 408
       global salmonella survey; 228
       gonococcal antimicrobial surveillance; 6, 269-271
       influenza reference centre; 10, 147, 150-151
       leptospirosis reference centre; 153
       poliomyelitis eradication; 44, s76, 118-120, 207, 209, 300-303, 304

Western Pacific Region; 1-4, 6, s76, 118-120, 207, 209, 269, 300, 302

Top of page

X

X-ray; 22

Y - Z

Yaws; 389

Yellow fever
       overseas briefs
              Brazil; 44, 54
              Guinea; 327
              Liberia; 263, 296
              Netherlands; 67
              Nigeria; 144
       vaccination; 54, s76, 263

In this section